tiprankstipranks
Trending News
More News >
dentalcorp Holdings (TSE:DNTL)
TSX:DNTL
Canadian Market
Advertisement

dentalcorp Holdings (DNTL) AI Stock Analysis

Compare
122 Followers

Top Page

TSE:DNTL

dentalcorp Holdings

(TSX:DNTL)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 4o)
Rating:64Neutral
Price Target:
C$11.50
▲(5.50% Upside)
dentalcorp Holdings' overall stock score is primarily driven by its strong technical indicators, suggesting bullish momentum. However, the company's financial performance is hindered by profitability challenges, which impacts its valuation negatively. The absence of earnings call data and corporate events means these factors do not influence the score.
Positive Factors
Revenue Growth
Steady revenue growth indicates expanding market presence and effective business model execution, supporting long-term financial health.
Cash Flow Position
Positive cash flow growth demonstrates strong operational efficiency, enabling reinvestment in growth initiatives and debt management.
Operational Efficiency
A strong gross profit margin highlights effective cost control, which can support profitability improvements and competitive positioning.
Negative Factors
Profitability Challenges
Persistent profitability issues can hinder long-term growth and shareholder returns, necessitating strategic focus on cost and revenue optimization.
Negative Return on Equity
Negative ROE indicates inefficiencies in capital use, potentially impacting investor confidence and future capital raising capabilities.
Net Profit Margin
A negative net profit margin suggests that revenue growth is not translating into profits, which could affect long-term sustainability and investment appeal.

dentalcorp Holdings (DNTL) vs. iShares MSCI Canada ETF (EWC)

dentalcorp Holdings Business Overview & Revenue Model

Company DescriptionDentalcorp Holdings (DNTL) is a leading dental service organization based in Canada that partners with dental practices to enhance operational efficiency and patient care. The company focuses on providing a comprehensive range of dental services, including general dentistry, orthodontics, and specialty care, while supporting its affiliated practices with management services, marketing, and technology solutions. Dentalcorp aims to improve the delivery of dental care through innovation and collaboration, positioning itself as a key player in the dental healthcare sector.
How the Company Makes MoneyDentalcorp generates revenue primarily through a service model that involves partnerships with dental practices. The company earns money by charging management fees to its affiliated dental clinics for various support services, including practice management, human resources, marketing, and procurement. Additionally, Dentalcorp may receive a percentage of the revenue generated by these clinics as part of their partnership agreements. Key revenue streams include patient care services, operational support, and potentially franchise-like fees from practices adopting its systems. Significant partnerships with dental supply companies and technology providers may also enhance its service offerings and revenue potential.

dentalcorp Holdings Earnings Call Summary

Earnings Call Date:Aug 08, 2025
(Q3-2024)
|
% Change Since: |
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Positive
The earnings call reflected a strong financial performance with significant growth in revenue, EBITDA, and free cash flow conversion. Strategic acquisitions and partnerships, particularly in AI technology, bolster future growth prospects. However, there are potential challenges with the continued rollout of the CDCP and interest rate expenses. Overall, the sentiment is positive due to the outweighing highlights.
Q3-2024 Updates
Positive Updates
Strong Revenue and EBITDA Growth
Revenue for Q3 2024 was $375.4 million, up 11.4% from Q3 2023. Adjusted EBITDA was $68.9 million, an increase of 13.1% over the same period.
Improved Free Cash Flow Conversion
Free cash flow conversion improved to 63% on an LTM basis, up from 58% in Q3 2023.
Successful M&A Activity
Acquired 4 practices for $16 million, expected to generate $2.3 million in pro forma adjusted EBITDA. Completed 9 acquisitions post-quarter-end, reaching the annual target of $20 million in acquired EBITDA.
Strategic Partnerships and Innovations
Formed a strategic partnership with VideaHealth to deploy AI technology across the network, enhancing clinical excellence and business efficiencies.
Deleveraging Efforts
Net leverage reduced to 4.0x, down 0.4x from the previous year, marking the fourth consecutive quarter of deleveraging.
Positive Outlook for Q4 2024
Anticipated revenue growth of 8% to 10% over Q4 2023, with adjusted EBITDA margins expected to increase by 20 basis points.
Negative Updates
Potential Disruption from CDCP Rollout
Uncertainty regarding the timing of the CDCP expansion to 18-64 age group could cause disruptions similar to the initial rollout in early 2024.
Interest Rate Challenges
Interest rate ceiling of 6% through January 2028, though improved from 6.6%, still represents a significant expense.
Company Guidance
During the Dentalcorp Q3 2024 earnings call, the company provided guidance indicating a robust financial performance with several key metrics. Dentalcorp reported a revenue of $375.4 million for the third quarter, marking an 11.4% increase from the same period in 2023. Adjusted EBITDA rose to $68.9 million, reflecting a 13.1% growth, while EBITDA margins improved by 30 basis points to 18.4%. The company also highlighted a same practice revenue growth of 4.2% for the quarter and achieved a free cash flow per share of $0.19, up by 36.4% year-over-year. They completed acquisitions adding $8.5 million in pro forma adjusted EBITDA after rent, bringing them close to their annual target of $20 million. Looking forward, Dentalcorp expects an 8% to 10% revenue increase in Q4 2024, with adjusted EBITDA margins projected to rise by 20 basis points compared to Q4 2023. Additionally, free cash flow conversion improved to 63% on an LTM basis, up from 58% in Q3 2023, with net leverage reduced to 4.0x, continuing a trend of deleveraging for the fourth consecutive quarter.

dentalcorp Holdings Financial Statement Overview

Summary
dentalcorp Holdings is experiencing steady revenue growth and has a solid cash flow position, which are positive indicators for future performance. However, the company faces challenges in profitability, as evidenced by negative net income and return on equity. The balance sheet is stable, with a manageable level of debt. To improve its financial standing, the company should focus on enhancing profitability while maintaining its growth trajectory.
Income Statement
65
Positive
dentalcorp Holdings has shown a consistent revenue growth trend, with a TTM revenue growth rate of 2.24%. However, the company is struggling with profitability, as indicated by a negative net profit margin of -3.66% and a modest EBIT margin of 1.12%. The gross profit margin is relatively healthy at 46.28%, suggesting efficient cost management. Overall, while revenue is growing, the company needs to improve its profitability metrics.
Balance Sheet
60
Neutral
The balance sheet shows a moderate debt-to-equity ratio of 0.78, indicating a balanced approach to leveraging. However, the return on equity is negative at -3.31%, reflecting challenges in generating returns for shareholders. The equity ratio stands at 51.63%, suggesting a stable capital structure. The company needs to focus on improving its profitability to enhance shareholder value.
Cash Flow
70
Positive
The cash flow statement reflects a positive trajectory, with a free cash flow growth rate of 9.06% in the TTM period. The operating cash flow to net income ratio is slightly above 1, indicating that the company generates sufficient cash from operations to cover its net losses. The free cash flow to net income ratio is 0.74, showing that while the company is not yet profitable, it is generating positive cash flows, which is a positive sign for future financial health.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.62B1.55B1.43B1.25B1.03B666.20M
Gross Profit809.20M772.70M493.70M611.90M495.40M321.60M
EBITDA234.80M222.20M197.40M183.40M75.10M99.70M
Net Income-45.10M-59.40M-85.60M-16.60M-160.40M-157.10M
Balance Sheet
Total Assets3.43B3.38B3.29B3.38B2.84B2.57B
Cash, Cash Equivalents and Short-Term Investments77.70M79.50M39.00M110.50M141.80M101.50M
Total Debt1.39B1.37B1.35B1.37B1.15B1.65B
Total Liabilities1.66B1.61B1.55B1.59B1.32B1.99B
Stockholders Equity1.77B1.77B1.74B1.79B1.51B584.00M
Cash Flow
Free Cash Flow167.30M147.10M123.80M106.00M36.80M-52.40M
Operating Cash Flow220.20M194.20M153.40M138.60M55.10M-35.20M
Investing Cash Flow-228.00M-170.80M-172.10M-419.80M-262.90M-151.30M
Financing Cash Flow13.20M16.50M-52.30M247.50M248.10M202.60M

dentalcorp Holdings Technical Analysis

Technical Analysis Sentiment
Positive
Last Price10.90
Price Trends
50DMA
9.54
Positive
100DMA
8.85
Positive
200DMA
8.42
Positive
Market Momentum
MACD
0.36
Positive
RSI
80.33
Negative
STOCH
54.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DNTL, the sentiment is Positive. The current price of 10.9 is below the 20-day moving average (MA) of 10.90, above the 50-day MA of 9.54, and above the 200-day MA of 8.42, indicating a neutral trend. The MACD of 0.36 indicates Positive momentum. The RSI at 80.33 is Negative, neither overbought nor oversold. The STOCH value of 54.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:DNTL.

dentalcorp Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
C$1.36B16.4665.09%3.23%8.68%39.93%
C$2.17B-46.41-2.58%0.69%9.94%35.48%
C$267.45M2.1241.13%2.49%-35.35%948.72%
C$1.82B49.456.94%4.89%10.13%1.30%
C$223.39M-2.17%0.56%-0.16%75.25%
$7.86B-0.30-43.30%2.27%22.53%-2.21%
C$1.26B-14.61%20.36%-186.10%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:DNTL
dentalcorp Holdings
10.90
1.47
15.59%
TSE:CRRX
CareRx
3.59
1.66
86.01%
TSE:EXE
Extendicare
16.06
7.29
83.12%
TSE:SIA
Sienna Senior Living
19.14
3.04
18.88%
TSE:DR
Medical Facilities
14.45
0.22
1.54%
TSE:WELL
WELL Health Technologies Corp
5.25
0.85
19.32%

dentalcorp Holdings Corporate Events

Business Operations and StrategyM&A Transactions
Dentalcorp to be Acquired by GTCR in C$2.2 Billion Deal
Positive
Sep 26, 2025

Dentalcorp Holdings Ltd. has agreed to be acquired by investment funds affiliated with GTCR in an all-cash transaction valued at approximately C$2.2 billion. This acquisition offers a 33% premium to the 20-day VWAP of Dentalcorp’s shares and has received support from shareholders representing 60.8% of the voting interest. The transaction, unanimously approved by Dentalcorp’s board, is expected to provide enhanced flexibility for the company to execute its long-term strategy, invest in technology, and expand its network of dental practices across Canada. GTCR’s experience in healthcare services is anticipated to support Dentalcorp’s growth and maintain its position as a leader in Canadian dentistry.

The most recent analyst rating on (TSE:DNTL) stock is a Hold with a C$8.50 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.

DividendsFinancial Disclosures
Dentalcorp Declares Dividend and Sets Date for Q3 2025 Results
Positive
Sep 19, 2025

Dentalcorp Holdings Ltd., a leading network of dental practices in Canada and North America, has announced a dividend of $0.025 per share for its Subordinate and Multiple Voting Shares, payable on October 21, 2025, to shareholders of record as of October 2, 2025. Additionally, the company will release its third-quarter 2025 financial results on November 6, 2025, before the market opens, followed by a conference call to provide a business update. This announcement highlights Dentalcorp’s commitment to rewarding its shareholders and maintaining transparency in its financial performance.

The most recent analyst rating on (TSE:DNTL) stock is a Hold with a C$8.50 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Dentalcorp Holdings Reports Strong Q2 2025 Financial Results and Expansion
Positive
Aug 8, 2025

Dentalcorp Holdings reported strong financial results for the second quarter of 2025, with revenue increasing by 8.9% to $435.2 million and Adjusted EBITDA growing by 9.9% to $81.2 million compared to the same period in 2024. The company also expanded its national presence by acquiring eight new practice locations, contributing to a record Adjusted Free Cash Flow of $45.6 million and a decrease in net debt ratio, indicating robust operational performance and strategic growth.

The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$13.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025